Cardiokinetix

Cardiokinetix is a medical device company based in Menlo Park, California, focused on improving cardiac function for patients with ischemic heart failure.

Founded in 2002, the company has developed the Parachute® Ventricular Partitioning Device, a catheter-based implant designed to treat heart failure by isolating dysfunctional areas of the heart ventricle. This innovative device helps restore normal cardiac geometry and enhances overall heart performance. The Parachute device is minimally invasive and is accompanied by a specialized delivery system for implantation. Cardiokinetix primarily serves healthcare providers, including cardiologists and hospitals, enabling them to offer advanced treatment options for patients suffering from left ventricular dilation after a heart attack. The company has successfully implanted the Parachute device in 500 patients and has raised significant funding to support its mission of changing the shape of heart failure.